SeaStar Medical (ICU) announced the company’s 1-for-10 reverse stock split, which will become effective as of 12:01 a.m. Eastern Time on January 5, 2026. The company’s common stock will begin trading on a post-split adjusted basis on The Nasdaq Capital Market effective with the open of the market on January 5, 2026. SeaStar Medical’s stock will continue to trade under the ticker symbol “ICU.” Authorization for the Reverse Split was approved by the company’s stockholders at SeaStar Medical’s 2025 Special Meeting of Stockholders held on December 18, 2025. The objective of the Reverse Split is to increase the market price for the company’s common stock to, among things, enable the company to regain compliance with the $1.00 minimum bid price requirement under applicable Nasdaq Listing Rules. The company’s common stock will trade under a new CUSIP number – 81256L302.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICU:
- SeaStar Medical Shareholders Approve 1-for-10 Reverse Split
- SeaStar reports approval for reduction in mandatory enrollment for SAVE registry
- Seastar Medical’s Earnings Call Highlights Growth and Challenges
- SeaStar Medical appoints Michael Messinger as CFO
- SeaStar Medical Reports Q3 2025 Financial Progress
